Aneuvo Is A Therapy Development Company Based In Los Angelescaliforniafounded In 2016The Company Focuses On Addressing Chronic Injuries And Conditions That Do Not Respond To Traditional Treatmentssuch As Spinal Cord Injuriesmultiple Sclerosisand Gastrointestinal Diseasesaneuvo Originated From Collaborative Research At Uclautilizing Expertise In Neuromodulationneuro Engineeringand Medical Device Development The Company Offers The Exastim Systema Non Invasive Neuromodulation Tool Aimed At Aiding Rehabilitation For Chronic Spinal Cord Injuriesadditionallyaneuvo Conducts The Aspire Studywhich Tests Neuromodulation Technology To Enhance Rehabilitation For Individuals With Long Term Motor Function Deficitstheir Technology Platform Develops Devices That Target Various Nervous Systemswith Applications In Neuromodulation And Neural Prostheses Aneuvo Has Raised $1 46 Million In Fundingincluding A Significant Grant From The National Science Foundationand Has Received Fda Breakthrough Device Designation For Some Of Its Therapiesthe Company Is Committed To Improving The Quality Of Life For Patients With Limited Treatment Options Through Innovativenon Invasive Solutions
